EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Tightens Solvent Tracing: Batch-Wise NOC Before Sale - India’s drug regulator has put the pharmaceutical supply chain on notice. A CDSCO communication dated 27 October 2026 directs State and Union Territory Drug Controllers to ensure that no batch of a specified high-risk pharmaceutical-grade solvent leaves a factory without being registered on the ONDLS portal and cleared with a system-generated No Objection Certificate (NOC). […]
NPPA Caps Cancer Drug Trade Margin at 30% From November 9 - India’s drug pricing authority has capped trade margins on a basket of anti-cancer medicines at 30 percent of the maximum retail price, with revised rates taking effect on November 9, 2026. The order from the National Pharmaceutical Pricing Authority (NPPA) revises ceiling prices across hundreds of brand packs and is expected to cut some maximum […]
CDSCO Cancels FatX Import Registration Over Misleading Claims - New Delhi: India’s drug regulator has cancelled the import registration of an injectable “fat-dissolving” product after concluding that its marketing claims strayed well beyond what the law allows for a cosmetic. The order, issued by the Central Drugs Standard Control Organisation (CDSCO) on 26 October 2026, withdrew registration certificate RC/COS-003300 for FatX Solution — a […]
CDSCO’s Risk-Based Regulation Push at iPHEX 2026 - The Central Drugs Standard Control Organization (CDSCO) is advancing a smarter, risk-based regulatory framework aimed at simplifying compliance for Indian pharmaceutical manufacturers while strengthening drug safety oversight. The initiative was highlighted at iPHEX 2026, India’s flagship pharma export showcase, where regulators and industry leaders discussed the future of drug regulation in the country. Why Risk-Based […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us